J. Garland

J.
Scott Garland is Chairman at LB Pharmaceuticals, Inc. since 2024.
Independent Director at Olema Pharmaceuticals, Inc. since 2023.
Independent Director at ALX Oncology Holdings, Inc. since 2022.
Director at Enliven Therapeutics, Inc. starting 2026.
Formerly President, Chief Executive Officer & Director at Portola Pharmaceuticals LLC from 2018 to 2020.
Director at PACT Pharma, Inc. in 2023.
Independent Director at Karyopharm Therapeutics, Inc. from 2014 to 2020.
Independent Director at Day One Biopharmaceuticals, Inc. from 2021 to 2026.
Independent Director at Calithera Biosciences, Inc. from 2020 to 2023.
Head-Sales & Marketing Division at Amgen, Inc. from 1997 to 2002.
Vice President-Avastin Franchise at Genentech, Inc. from 2002 to 2011.
Chief Commercial Officer & Executive VP at Exelixis, Inc. from 2011 to 2014.
President at Relypsa, Inc. from 2017 to 2018.
Venture Partner at VV Manager LLC.
Education includes undergraduate degree from California Polytechnic State University (San Luis Obispo) and MBA from The Fuqua School of Business.